Solid Organ Transplantation Technologies and Growth Opportunities

Solid Organ Transplantation Technologies and Growth Opportunities

Next-generation Sequencing-based Transplant Diagnostics and Normothermic Organ Perfusion Technologies Enabling Better Post-transplant Outcomes and Increases Donor Organ Availability

RELEASE DATE
24-Nov-2022
REGION
Global
Deliverable Type
Technology Research
Research Code: DA7C-01-00-00-00
SKU: HC03606-GL-TR_27151
AvailableYesPDF Download

$4,950.00

Special Price $4,207.50 save 15 %

In stock
SKU
HC03606-GL-TR_27151

Solid Organ Transplantation Technologies and Growth Opportunities
Published on: 24-Nov-2022 | SKU: HC03606-GL-TR_27151

Need more details?

$4,950.00

$4,207.50save 15 %

DownloadLink
Need more details?

The organ donation and transplant community is facing a constant scarcity of adequate donor organs to meet the unceasingly increasing demand. All innovations in the solid organ transplant industry focus on increasing the availability of donor organs and improving post-transplant outcomes post-transplant. Pre- and post-transplant diagnostics are used for recipient evaluation, donor matching, diagnosis of infectious diseases, immunosuppression monitoring, and organ rejection monitoring. Diagnostics are now using novel molecular assay techniques, advanced optical sensors, device miniaturization, and data analytics. Advances in organ preservation and perfusion device technologies include novel preservation solutions, and remote monitoring technologies during storage, enabling safe storage and transport of the organ. Innovation also revolves around the treatment of marginal organs during storage, which would increase the availability of organs.
This research service analyzes transplant diagnostics and organ preservation devices and explores the drivers and restraints to the growth of the solid organ transplant industry. The increasing incidence of chronic diseases and organ failures, the technological advancements in diagnostics and organ preservation technologies, and the unmet need to improve post-transplant outcomes are the top drivers in the organ transplantation market.
The need for efficient donor referrals, donor-matching, and post- or pre-transplant patient management provides opportunities for transplant diagnostics companies and AI and digital solutions providers to expand their portfolio of applications. New cryopreservants, sub-normothermic perfusion, and controlled oxygen rewarming allow longer and safer preservation.
The study covers global transplant diagnostics and organ preservation device technologies, their categories, and their advantages and disadvantages. The competitive environment explores technologies employed by key participants, overall technology adoption, and its impact on solid organ transplants. The study covers technology roadmaps for transplant diagnostics and organ preservation devices, recent government and private funding activities, patent filling and M&A trends, and top growth opportunities for key companies.

The organ donation and transplant community is facing a constant scarcity of adequate donor organs to meet the unceasingly increasing demand. All innovations in the solid organ transplant industry are fixated on increasing the availability of donor organs and improving the outcomes post-transplant. The research report focuses on transplant diagnostics and organ preservation devices.

The pre- and post-transplant diagnostics are used for recipient evaluation, donor matching, diagnosis of infectious diseases, immunosuppression monitoring and organ rejection monitoring. The diagnostics are advancing with novel molecular assay techniques, advanced optical sensors, device miniaturization and data analytics. The advances in organ preservation and perfusion device technologies, preservation solutions, biomaterials and remote monitoring technologies during storage enable safe storage of the organ during the transport to the recipient. Innovations also allow treatment of marginal organs during the storage, thereby increasing the availability of organs.

The increasing incidence of chronic diseases and organ failures, the technological advancements in diagnostics and organ preservation technologies and the need to improve post-transplant outcomes will drive the market. But, the organ preservation time, device performance, cost-efficiency and portability of the technologies needs to be improved. The need for efficient donor referrals, donor-matching and post or pre transplant patient management provides opportunities for both the diagnostics companies and the AI and digital solutions providers to expand their portfolio of applications. Whereas ongoing research on new preservation techniques, solutions and donated organs provide opportunities for the organ preservation companies. New cryo-preservants, sub-normothermic perfusion and controlled oxygen rewarming are allowing longer and safer preservation.

The study covers global transplant diagnostics and organ preservation device technologies. The study provides an overview for the different categories of the transplant diagnostics and organ preservation technologies, their advantages and disadvantages. The drivers and restraints to the growth of the solid organ transplant industry are discussed. The competitive environment in the different segments of the industry and the technologies employed by the key players are explored. Adoption of the different technologies and their impact on the solid organ transplants has been analyzed. The technology roadmaps of the transplant diagnostics and organ preservation devices are also provided. Recent government and private funding activities and M&A trends in the industry segments have been analyzed. The growth opportunities for the key companies and the patent filing trend in the industry have also been put forth.

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Solid Organ Transplant Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Solid Organ Transplantation—Overview

Trends in Solid Organ Transplantation

Solid Organ Transplantation Workflow

Challenges in Solid Organ Transplantation

Technology Advances Impacting the Different Stages of Organ Transplantation

Segmentation

Growth Drivers

Growth Restraints

Growth Metrics

Scope of Analysis

Transplant Diagnostics—Overview

Classification of Transplant Diagnostics

Molecular Transplant Diagnostics

Nonmolecular Transplant Diagnostics

Notable Recent Activities Advancing Transplant Diagnostics

Transplant Diagnostics—Competitive Environment

Transplant Diagnostics—Competitive Environment (continued)

Comparison of the Features of the Transplant Diagnostics Technologies

Transplant Diagnostic Technologies—Adoption and Impact Analysis

Technology Roadmap of Transplant Diagnostics

Organ Preservation Devices—Overview

Classification of Organ Preservation Technologies

Static Cold Storage

Hypothermic Organ Perfusion

Normothermic Organ Perfusion

Common Organ Preservation Solutions and Their Compositions

Notable Recent Activities Advancing Organ Preservation Devices

Organ Preservation Devices—Competitive Environment

Organ Preservation Devices—Competitive Environment (continued)

Organ Preservation Devices—Competitive Environment (continued)

Comparison of the Features of the Organ Preservation Device Technologies

Organ Preservation Device Technologies—Adoption and Impact Analysis

Technology Roadmap of Organ Preservation Devices

Analysis of M&As in the Transplant Diagnostics Industry, 2019–2022

Analysis of Government Funding for Transplant Diagnostics, 2019–2022

Snapshot of Private Funding for Transplant Diagnostics, 2019–2022

Analysis of M&As in the Organ Preservation Devices Industry, 2019–2022

Analysis of Government Funding for Organ Preservation Devices, 2019–2022

Snapshot of Private Funding for Organ Preservation Devices, 2019–2022

Innovation Themes and IP Activity Analysis in Transplant Diagnostics

Innovation Themes and IP Activity Analysis in Organ Preservation Devices

Patents, 2021–2022

Patents, 2021–2022

Patents, 2021–2022

Growth Opportunity 1: AI-enabled Transplant Diagnostics

Growth Opportunity 1: AI-enabled Transplant Diagnostics (continued)

Growth Opportunity 2: eHealth Services and Transplant Management Solutions

Growth Opportunity 2: eHealth Services and Transplant Management Solutions (continued)

Growth Opportunity 3: New Organ Preservation Technologies

Growth Opportunity 3: New Organ Preservation Technologies for Increased Organ Availability (continued)

Technology Readiness Levels (TRL): Explanation

Your Next Steps

Why Frost, Why Now?

Legal Disclaimer

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The organ donation and transplant community is facing a constant scarcity of adequate donor organs to meet the unceasingly increasing demand. All innovations in the solid organ transplant industry focus on increasing the availability of donor organs and improving post-transplant outcomes post-transplant. Pre- and post-transplant diagnostics are used for recipient evaluation, donor matching, diagnosis of infectious diseases, immunosuppression monitoring, and organ rejection monitoring. Diagnostics are now using novel molecular assay techniques, advanced optical sensors, device miniaturization, and data analytics. Advances in organ preservation and perfusion device technologies include novel preservation solutions, and remote monitoring technologies during storage, enabling safe storage and transport of the organ. Innovation also revolves around the treatment of marginal organs during storage, which would increase the availability of organs. This research service analyzes transplant diagnostics and organ preservation devices and explores the drivers and restraints to the growth of the solid organ transplant industry. The increasing incidence of chronic diseases and organ failures, the technological advancements in diagnostics and organ preservation technologies, and the unmet need to improve post-transplant outcomes are the top drivers in the organ transplantation market. The need for efficient donor referrals, donor-matching, and post- or pre-transplant patient management provides opportunities for transplant diagnostics companies and AI and digital solutions providers to expand their portfolio of applications. New cryopreservants, sub-normothermic perfusion, and controlled oxygen rewarming allow longer and safer preservation. The study covers global transplant diagnostics and organ preservation device technologies, their categories, and their advantages and disadvantages. The competitive environment explores technologies employed by key participants, overall technology adoption, and its impact on solid organ transplants. The study covers technology roadmaps for transplant diagnostics and organ preservation devices, recent government and private funding activities, patent filling and M&A trends, and top growth opportunities for key companies.--BEGIN PROMO--

The organ donation and transplant community is facing a constant scarcity of adequate donor organs to meet the unceasingly increasing demand. All innovations in the solid organ transplant industry are fixated on increasing the availability of donor organs and improving the outcomes post-transplant. The research report focuses on transplant diagnostics and organ preservation devices.

The pre- and post-transplant diagnostics are used for recipient evaluation, donor matching, diagnosis of infectious diseases, immunosuppression monitoring and organ rejection monitoring. The diagnostics are advancing with novel molecular assay techniques, advanced optical sensors, device miniaturization and data analytics. The advances in organ preservation and perfusion device technologies, preservation solutions, biomaterials and remote monitoring technologies during storage enable safe storage of the organ during the transport to the recipient. Innovations also allow treatment of marginal organs during the storage, thereby increasing the availability of organs.

The increasing incidence of chronic diseases and organ failures, the technological advancements in diagnostics and organ preservation technologies and the need to improve post-transplant outcomes will drive the market. But, the organ preservation time, device performance, cost-efficiency and portability of the technologies needs to be improved. The need for efficient donor referrals, donor-matching and post or pre transplant patient management provides opportunities for both the diagnostics companies and the AI and digital solutions providers to expand their portfolio of applications. Whereas ongoing research on new preservation techniques, solutions and donated organs provide opportunities for the organ preservation companies. New cryo-preservants, sub-normothermic perfusion and controlled oxygen rewarming are allowing longer and safer preservation.

The study covers global transplant diagnostics and organ preservation device technologies. The study provides an overview for the different categories of the transplant diagnostics and organ preservation technologies, their advantages and disadvantages. The drivers and restraints to the growth of the solid organ transplant industry are discussed. The competitive environment in the different segments of the industry and the technologies employed by the key players are explored. Adoption of the different technologies and their impact on the solid organ transplants has been analyzed. The technology roadmaps of the transplant diagnostics and organ preservation devices are also provided. Recent government and private funding activities and M&A trends in the industry segments have been analyzed. The growth opportunities for the key companies and the patent filing trend in the industry have also been put forth.

More Information
Deliverable Type Technology Research
Author Sneha Maria Mariawilliam
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number DA7C-01-00-00-00